Two cases of congenital myotonic dystrophy type 1 caused by DMPK gene variants

Xiao-Hong WANG, Chen-Hong WANG, Yan-Ping XU, Xiao-Lu MA, Li-Ping SHI, Zheng CHEN, Shan-Shan MAO

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (4) : 498-501.

PDF(894 KB)
HTML
PDF(894 KB)
HTML
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (4) : 498-501. DOI: 10.7499/j.issn.1008-8830.2508148
CASE REPORT

Two cases of congenital myotonic dystrophy type 1 caused by DMPK gene variants

Author information +
History +

Abstract

Patient 1 was a male neonate who, at 3 hours of life, presented with respiratory distress, hypotonia, and ventilator dependence. Genetic testing revealed a DMPK gene CTG repeat expansion (13/>83). Patient 2 was a male neonate who presented at 2 days of life after resuscitation for perinatal asphyxia, with hypotonia and ventilator dependence, complicated by hypoxic-ischemic encephalopathy and diaphragmatic eventration, which appears to represent the first such combination reported in China. Genetic testing showed a DMPK gene CTG repeat expansion (12/>83). Both cases were diagnosed with congenital myotonic dystrophy type 1. Congenital myotonic dystrophy type 1 is a rare and severe genetic disorder with low survival. When characteristic clinical manifestations appear, genetic testing and family counseling should be performed as early as possible to guide future pregnancies and reduce birth defects.

Key words

Congenital myotonic dystrophy type 1 / DMPK gene / Diaphragmatic eventration / Hypotonia / Infant

Cite this article

Download Citations
Xiao-Hong WANG , Chen-Hong WANG , Yan-Ping XU , et al . Two cases of congenital myotonic dystrophy type 1 caused by DMPK gene variants[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(4): 498-501 https://doi.org/10.7499/j.issn.1008-8830.2508148

References

[1]
VANIER TM. Dystrophia myotonica in childhood[J]. Br Med J, 1960, 2(5208): 1284-1288. PMCID: PMC2097012. DOI: 10.1136/bmj.2.5208.1284 .
[2]
Pearson CE, Wang YH, Griffith JD, et al. Structural analysis of slipped-strand DNA (S-DNA) formed in (CTG)n. (CAG)n repeats from the myotonic dystrophy locus[J]. Nucleic Acids Res, 1998, 26(3): 816-823. PMCID: PMC147324. DOI: 10.1093/nar/26.3.816 .
[3]
Freudenreich CH. R-loops: targets for nuclease cleavage and repeat instability[J]. Curr Genet, 2018, 64(4): 789-794. PMCID: PMC6039234. DOI: 10.1007/s00294-018-0806-z .
[4]
Zapata-Aldana E, Ceballos-Sáenz D, Hicks R, et al. Prenatal, neonatal, and early childhood features in congenital myotonic dystrophy[J]. J Neuromuscul Dis, 2018, 5(3): 331-340. DOI: 10.3233/jnd-170277 .
[5]
李恒, 吕小明, 武辉, 等. 病例06(2025): 先天型强直性肌营养不良2例[J]. 中华围产医学杂志, 2025, 28(4): 326-331. DOI: 10.3760/cma.j.cn113903-20241128-00791 .
[6]
吕少广, 刘芳, 栗静, 等. 先天型强直性肌营养不良1型1例[J]. 中华新生儿科杂志(中英文), 2023, 38(6): 365-366. DOI: 10.3760/cma.j.issn.2096-2932.2023.06.009 .
[7]
Peglar LM, Nagaraj UD, Tian C, et al. White matter lesions detected by magnetic resonance imaging in neonates and children with congenital myotonic dystrophy[J]. Pediatr Neurol, 2019, 96: 64-69. DOI: 10.1016/j.pediatrneurol.2019.03.004 .
[8]
武慧, 王晶, 孙晋波, 等. 先天性强直性肌营养不良1例[J]. 中华新生儿科杂志, 2022, 37(3): 271-272. DOI: 10.3760/cma.j.issn.2096-2932.2022.03.020 .
[9]
Chang L, Ernst T, Osborn D, et al. Proton spectroscopy in myotonic dystrophy: correlations with CTG repeats[J]. Arch Neurol, 1998, 55(3): 305-311. DOI: 10.1001/archneur.55.3.305 .
[10]
Pezzoli F, Parigi S, Moroni M, et al. Diaphragmatic hernia in a term newborn with congenital myotonic dystrophy: case report[J]. Acta Biomed, 2023, 94(S1): e2023097. DOI: 10.23750/abm.v94iS1.13822 .
[11]
Yee C, Choi SJ, Oh SY, et al. Clinical characteristics of pregnancies complicated by congenital myotonic dystrophy[J]. Obstet Gynecol Sci, 2017, 60(4): 323-328. PMCID: PMC5547078. DOI: 10.5468/ogs.2017.60.4.323 .
[12]
Trucco F, Albamonte E, Pane M, et al. Parental diagnostic delay and developmental outcomes in congenital and childhood-onset myotonic dystrophy type 1[J]. Dev Med Child Neurol, 2025, 67(3): 365-373. PMCID: PMC11794672. DOI: 10.1111/dmcn.16079 .
[13]
Thornton CA, Moxley RT, Eichinger K, et al. Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial[J]. Lancet Neurol, 2023, 22(3): 218-228. DOI: 10.1016/s1474-4422(23)00001-7 .
[14]
Rizzo M, Beffy P, Del Carratore R, et al. Activation of the interferon type I response rather than autophagy contributes to myogenesis inhibition in congenital DM1 myoblasts[J]. Cell Death Dis, 2018, 9(11): 1071. PMCID: PMC6195593. DOI: 10.1038/s41419-018-1080-1 .

Footnotes

所有作者均声明无利益冲突。

PDF(894 KB)
HTML

Accesses

Citation

Detail

Sections
Recommended

/